Codiak BioSciences, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2019 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Codiak BioSciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2019 to Q3 2022.
  • Codiak BioSciences, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2022 was $2.12M.
  • Codiak BioSciences, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was $35.9M.
  • Codiak BioSciences, Inc. annual Nonoperating Income (Expense) for 2021 was $32.4M.
  • Codiak BioSciences, Inc. annual Nonoperating Income (Expense) for 2020 was -$747K, a 134% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $35.9M $2.12M +$2.32M Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $33.6M $242K +$585K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $33M $223K +$584K Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $32.4M $33.3M +$33.7M Oct 1, 2021 Dec 31, 2021 10-K 2022-03-10
Q3 2021 -$1.26M -$206K +$59K +22.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$1.32M -$343K -$223K -186% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$1.1M -$361K -$349K -2908% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$747K -$350K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$265K -$832K -147% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$120K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$12K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2019 $567K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.